In breast cancer the presence of cells undergoing the epithelial-to-mesenchymal transition is indicative of metastasis progression. Since metabolic features of breast tumour cells are critical in cancer progression and drug resistance, we hypothesized that the lipid content of malignant cells might be a useful indirect measure of cancer progression. In this study Multivariate Curve Resolution was applied to cellular Raman spectra to assess the metabolic composition of breast cancer cells undergoing the epithelial to mesenchymal transition. Multivariate Curve Resolution analysis led to the conclusion that this transition affects the lipid profile of cells, increasing tryptophan but maintaining a low fatty acid content in comparison with highly metastatic cells. Supporting those results, a Partial Least Square-Discriminant analysis was performed to test the ability of Raman spectroscopy to discriminate the initial steps of epithelial to mesenchymal transition in breast cancer cells. We achieved a high level of sensitivity and specificity, 94% and 100%, respectively. In conclusion, Raman microspectroscopy coupled with Multivariate Curve Resolution enables deconvolution and tracking of the molecular content of cancer cells during a biochemical process, being a powerful, rapid, reagent-free and non-invasive tool for identifying metabolic features of breast cancer cell aggressiveness at first stages of malignancy.
Introduction
Genetically altered neoplastic cells have special metabolic requirements [1] . Recent molecular studies of cancer revealed that oncogenes directly affect cellular energy metabolism [2] .
An early and universal feature of tumours is the activation of lipid metabolism secondary to the activation of the lipogenic enzymes in the malignant process [3] . Increased lipogenesis is a hallmark of many cancers including breast carcinomas [4] . Lipid metabolism related genes in breast cancer cells have been studied describing a lipogenic phenotype [3] . Gene silencing experiments with seven genes (ACACA, ELOVL1, FASN, INSIG1, SCAP, SCAP, SCD, THRSP) indicated that reduction of the lipidomic profiles disrupted the viability of breast cancer cells [5] .
In addition, the constitutive activation of signalling cascades that stimulate cell growth has a profound impact on anabolic metabolism [6] . One of the principal mechanisms of aerobic glycolysis resides in the activation of hypoxia-inducible factor (HIF), a transcription factor activated by hypoxic, oncogenic, metabolic and oxidative stress, and also involved in epithelial-to-mesenchymal transition (EMT), the initial signal of the lethal metastatic phenotype of breast cancer cells [7] . Indeed, the preferential expression of EMT-related genes has been found in basal-like breast tumours, the most invasive breast carcinomas [8] with the worst prognosis and greatest resistance to chemotherapy [9] . Basal-like tumour cells express markers characteristic of the normal mammary gland myoepithelium, such as epidermal growth factor receptor (EGFR), p63 and basal cytokeratins CK14, CK5/6 and CK17 [10] . Cellular remodelling occurring as a consequence of EMT, whereby cells have altered responses to agents in the circulatory system or secondary tumour site, could be advantageous for the process of metastasis [11, 12] . EMT confers mesenchymal properties on epithelial cells and has been closely associated with the acquisition of aggressive traits by carcinoma cells [13] . Moreover, the dynamic interactions among epithelial, self-renewal and mesenchymal gene programmes determine the plasticity of epithelial tumour-initiating cells [14] .
A close relationship between changes in fatty acid metabolism is associated to cell motility and the proclivity to breast cancer cells undergoing EMT [15] . We have previously characterized the metabolic phenotype of breast cancer cells by using Raman microspectroscopy (RS) combined with Principal Component Analysis (PCA), based on a panel of small molecules derived from the global or targeted analysis of metabolic profiles of cells [15] . RS combined with PCA has emerged as a useful technique for stratifying breast cell malignancy, being well correlated with the EMT phenotype and the expression of SREBP-1c and ABCA1 genes [16] . Since, metabolic features of breast tumour cells are critical in cancer progression and drug resistance [9, 17] , there exists a need to develop alternative/adjunct, user-freed, cost effective, rapid, objective and unambiguous methods for the early detection and diagnosis of metastatic breast cancer cells.
Recently, some unmixing algorithms have been used to decompose the Raman spectra into different molecular components in areas such as Raman imaging: Vertex Component Analysis (VCA) [18] [19] [20] and Multivariate Curve Resolution (MCR) [21] . In the last decade, MCR algorithm has been applied in a broad range of chemical analysis [22] [23] [24] and recently to Raman images [25, 26] . Multivariate Curve Resolution-Alternating Least Squares (MCR-ALS) stands out because of its flexibility to include initial estimates and constrains in the iterative resolution procedure [21] . The output of the MCR-ALS analysis gives more chemically and physically understandable results than classical techniques such as PCA, where only a mathematical exploration of the data can be performed [27] [28] [29] [30] . Thus, being a powerful candidate tool to deconvolve key molecular signatures from the Raman spectra and monitor the biochemical composition of the sample over the process studied [31] . In the present research we used MCR-ALS algorithm to study cellular Raman spectra. The algorithm allowed the deconvolution of meaningful molecular Raman spectra of biomolecules (metabolites) that change its concentration in the cells under study. Furthermore, and supporting MCR results, a Partial Least Square-Discriminant analysis (PLS-DA) was performed to test the ability of discrimination with RS of the EMT from initiating breast cells, achieving a high level of sensitivity and specificity. Overall the results presented in this paper report the first application of MCR to RS to deconvolve and track the molecular content of initiating breast cancer cells during the EMT process, suggesting that RS combined with MCR and PLS-DA is a powerful diagnostic tool for identifying metabolic features of the first stages of malignancy and breast cancer cell aggressiveness.
Material and methods

Cell cultures
MCF10A cells were obtained from the American Type Culture Collection and were grown in DMEM/F12 medium supplemented with 5% horse serum, 1 mM pyruvate, 2 mM L-glutamine, 0.01 mg/ml bovine insulin, 20 ng/ml EGF, 1 mg/ml hydrocortisone and 100 ng/ml tetanus toxin in 5% CO 2 -95% air at 37°C in a humidified incubator.
MDA-MB-435 cells maintained under standard conditions in a 1:1 (v/v) mixture of DMEM and Ham F12 medium (DMEM/F12) supplemented with 10% foetal bovine serum (FBS), 1 mM pyruvate and 2 mM L-glutamine, in the same incubator conditions as described above were used in some experiments [32] .
Sample preparation
Each measurement required 3 × 10 5 cells, or 3 × 10 4 cells for MCF10A cells in confluent or sparse conditions. Cells were seeded in six-well plates (Becton Dickinson, NJ) over a quartz crystal (ESCO products, Oak Ridge, NJ), which was used to reduce the background signal. After 24 h, the cells were fixed with 4% cold paraformaldehyde (PFA) in PBS 1× for 15 min, washed 3 times for 10 min with PBS 1× (until no PFA residues were present) and maintained in the same PBS 1 × solution at 4°C until measurements. The complete washing of the cells also ensures that no residues of different culture media or other chemicals are present and therefore the cells are measured under the same conditions.
Raman spectroscopy
The Renishaw Raman system (Apply Innovation, Gloucestershire, UK) comprises a 514 nm laser that supplies an excitation beam of about 5 mW power, which is focused onto the sample via a microscope using an air 60× objective (Leica, 0.75 NA). The same objective collects the scattered light from the sample and directs it to the spectrometer. The spectrometer processes this scattered light, by rejecting the unwanted portion and separating the remainder into its constituent wavelengths. The Raman spectrum is recorded on a deep depletion charge-coupled device (CCD) detector (Renishaw RenCam). The recorded Raman spectrum is digitalized and displayed on a personal computer using Renishaw WiRE software, which allows the experimental parameters to be set. For experiments, one spectrum was collected per cell in the cytoplasm, near the nucleus but outside the endothelial reticulum [15] , focusing light at 3 μ inside the quartz window. We were interested in obtaining the most number of cells measured rather than study the intracellular domain. That is why we acquired one Raman spectra per cell, obtaining a total of 20 spectra per cell line studied: MCF10 confluent, MCF10 sparse and MDA-MB-435. To ensure that changes in the spectra among different cell lines were due to its intrinsic biochemical content and not due to changes in other factors that could be out of control (setup alignment, background signals, temperature, conditions in sample preparation …), we measure all cell lines in the same day under exactly the same conditions. Replications of the experiment were performed in other different days and were comparable, providing similar results. The quartz in which the cells were grown and fixed was translated to a magnetic fluid chamber (Live Cell Instruments), filled with PBS and closed with other quartz coverslip. For Raman measurements the quartz containing the cells was placed on the top (with cells inside the fluid chamber) to be measured with the upright microscope.
Before including Raman spectra in the multivariate statistical techniques, correct pre-processing must be performed. Spectra shown in Fig. 1 have been pre-processed using the following methods: subtracting fluorescence background [15] , comic spike removal, smoothing (5 points averaging) and multiple scattering correction (MSC); MSC algorithm was used to correct for differences in global intensity among the spectra. We used a custom-made Labview and Matlab code to perform all these preprocessing methods. However because there is still the presence of background signals from quartz or PBS, with the use of MCR-ALS algorithm we subtracted those signals at the same time that we looked for molecular components (explained in the next section on Statistical analysis). For Raman spectral analysis, the region between 1015 and 1110 cm −1 was removed because it contained a background-related signal that reduced the quality and interpretability of our statistical models. 
Statistical analysis
Two multivariate techniques were performed on cellular Raman spectra, in order to evaluate the spectral differences among the cancerous cell lines studied and to develop a model allowing their discrimination and classification: MCR and PLS-DA.
In Multivariate Curve Resolution (MCR) [21] , a bilinear relation of the spectrum is assumed from the matrix, taking into account that the total Raman spectra contained in X matrix can be modelled as the contribution of pure molecular spectra (S) multiplied by the concentration of each pure molecular component (C), X = CS T + E, where X is the Raman spectra acquired matrix, C is the concentration matrix transposed and E is the matrix of spectral errors. The algorithm used was Multivariate Curve Resolution-Alternating Least Squares (MCR-ALS). Using a first PCA on the dataset of spectra, the number of components necessary to explain the variance in the data was selected, accounting for 95% of the total variance. For ALS optimization, constraints of non-negativity in the spectra and concentrations were applied. A limit of 300 iterations was applied to reach the 0.95 confidence limits. MCR-ALS allowed visualization of the bands (biomolecular vibrations) responsible for the changes in metabolite concentrations in the different cell lines. Finally, five molecular components were deconvolved from the spectra.
In order to deconvolve from the spectra the possible contributions of the background signals we include in the Raman spectra matrix X, 5 spectra obtained from the PBS solution at the same focal distance where the cells were measured (3 μm). In this way, the algorithm extracts one component that contains the spectral profiles of background signals from the quartz window and PBS solution. These five spectra are represented by stars in the plots and they always contain very low levels of other cellular components as expected. A remaining contribution from quartz signal was arising at 1100 cm −1 in other components, and for this reason we exclude from the analysis this region to ensure that the components deconvolved were not mixed with background signals. PLS-DA [15] is a supervised classification method in which knowledge of the sample is included (in our case metastatic, malignant and benign MCF10A phenotypes). PLS-DA employs the fundamental principle of PCA but further rotates the component (latent variables, LVs) by maximizing the covariance between the spectral variation and group affinity so that the LVs explain the diagnostically relevant variations rather than the most prominent variations in the spectral dataset.
The performance of the PLS-DA diagnostic algorithm was validated using leave-one-out cross validation methodology. The number of retained LVs was determined based on the minimal root mean square error of cross validation (RMSECV) curves.
Multivariate statistical analysis was performed using the PLS toolbox (Eigenvector Research, Wenatchee, WA) in the Matlab (Mathworks Inc., Natick, MA) programming environment. Before including Raman spectra in the multivariate statistical techniques, correct preprocessing must be performed (see Raman spectroscopy section).
Gene expression analysis
Transcriptomic data from MCF10A cells cultured in sparse or confluent conditions with accession number GSE8430 [12] were downloaded from the Gene Expression Omnibus database [33] . In addition, a series of matrix including normalized data from GSE18070 that contains different strands of k-ras transfected MCF10A cells was downloaded from the GEO repository [33] . The median z-score between the six replicates included in the experiment was calculated for each probe and then used to rank all genes by their level of expression. To assess gene expression differences, a t-test between all probe sets from three hybridized MIII samples (cells with ability to metastasize in vivo) and three MII samples (cells without metastasis ability) was conducted. Then the 33,853 genes included in the array (Affymetrix U133 Plus 2.0) were ranked based on their statistic expression level.
A pre-ranked GSEA (Gene Set Enrichment Analysis) using both lists of ranked genes was run. Only 81 gene sets were related to "fatty acid", "lipid", "glucose", "cholesterol", "EMT" and "tryptophan"; and those gene sets were described by Charafe et al. [34] including differentially expressed genes between different kinds of breast cancer that were included in the analysis. The statistical significance of the enrichment score was calculated by permuting the genes 1000 times as implemented in the GSEA software. Functional terms were considered to be significant at FDR q-value of 25%.
The conventional statistical methods for microarray gene expression analysis choose a list of differentially expressed genes based on a p-value corrected by multi-testing. Using this astringent criterion, a large number of genes that do in fact contribute to the studied phenotype could be missed. The GSEA (gene set enrichment analysis) approach was designed to address the limitation of single gene analysis since it uses all transcriptomic information included in the array [35] .
All computations were performed using R statistical software and Bioconductor [36] .
Results
Multivariate Curve Resolution (MCR) algorithm provides an accurate evaluation of Raman spectroscopy (RS)
We use MCR to efficiently disentangle pure molecular information encoded in complex spectrum such as Raman.
To distinguish the metabolic features of cells with the EMT phenotype [37, 38] , we used MCF10A cells, benign breast tumour cells, unable to spread outside the basal membrane, despite their basal-like phenotype. It has been described that MCF10A sparse cultures presented many features of mesenchymal cancer when compared with MCF10A confluent [12] . The more aggressive MDA-MB-435 cell line showed an even more noticeable mesenchymal phenotype characterized by a high level of expression of vimentin and N-cadherin [39, 40] and a down-regulation of E-cadherin [40] . Therefore we used MCF10A confluent and sparse culture conditions as a signal of the initiation of metastasis progression, to characterize the spectroscopic parameters of a prototype of metastasis-initiating cells in comparison with the highly metastatic MDA-MB-435 breast cancer cells, a widely recognized metastatic cells in which the degree of metastaticity has been related to the polyunsaturated fatty acid contents by Raman analysis [41] .
Since we have previously distinguished confluent and sparse MCF10A, according to the total unsaturated fatty acids (TUFA) band intensity (in the C\H stretching region of the spectra (2800-3100 cm −1 ), [15] , RS of both phenotypes (confluent and sparse MCF10A) was acquired in the fingerprint region (600-1800 cm −1 ). Fig. 1 shows the row spectrum of the three different phenotypic cells analysed (MCF10 sparse, confluent and MDA-MB-435) after background subtraction and MSC correction. Band characteristic of the Raman spectra of molecules is presented in Table 1 . The MCR-ALS algorithm was then used to deconvolve from these raw spectra the Raman spectra of the metabolites that differed among the cell groups. One problem that could arise in resolution analysis methods is that the components deconvolved from the experimental Raman spectra are mixed with background signals and are therefore difficult to interpret. This problem was solved by adding to the data set a small number of spectra obtained from the PBS (buffer, not cells) at the same focal distance at which the cellular spectra were acquired. Including this extra information in the MCR-ALS algorithm allows the deconvolution of a component that contains only background spectra (quartz and water). Therefore, the remaining components only account for the differences in the metabolite content in the cells. Four pure spectra were deconvolved from inherent cellular components and are shown in Fig. 2 . Score plots relating to different components are presented in Fig. 3 . The control spectra from PBS were plotted on the score plot as blue crosses and were always around the lowest levels of the concentration of the different cellular metabolites, indicating the absence of those molecules from the spectra.
With the help of previously published Raman databases [42] [43] [44] [45] and measuring the Raman spectra of pure molecules, we identified component 1 as tryptophan, component 2 as fatty acids and component 5 as cytokeratin. Component 4 did not have a priori clear assignment, whereas component 3 accounted only for background contribution (Fig. 2) . Table 1 lists the assigned metabolites in each component [43, 44] ). Therefore, MCR resolved meaningful components in the spectra with respect to classical techniques such as Principal Component Analysis (PCA), demonstrating a high capacity to deconvolve the pure cell component spectra of molecules from a set of Raman spectra. Moreover, the outputs of the statistical analysis provided more chemically and physically understandable results than classical techniques such as PCA, via which only a mathematical exploration of the data can be performed and components have mixed molecular contributions and negative loadings. 
RS dissects the metabolic phenotype of EMT in breast cancer cells
We conducted an in-depth analysis of the most significant differences between confluent and sparse MCF10A cells to assess the different profiles of the spectral composition and to build a classification algorithm for the discrimination of EMT cells with the metastaticinitiating phenotype from the highly metastatic MDA-MB-435 cells.
We plotted the contributions of component 2 (fatty acids) with respect to component 5 (keratin) (Fig. 3a) . EMT appeared inversely correlated with keratin, with MDA-MB-435 cells having low keratin level whereas confluent MCF10A cells had the highest (Fig. 3a and c) . Component 2 (fatty acid) separated two MDA-MB-435 cell populations: SP435A with the highest fatty acid content, and SP435B with a moderate fatty acid increase. In contrast, sparse MCF10A cells had a low keratin and increased fatty acid content compared with confluent MCF10A cells, more similar to SP435A. Indeed, the most lipid accumulating cells were sparse MCF10A and SP435A. Thus, RS accurately classified EMT based on a low keratin and a high lipid content, so-called lipid phenotype (LP). In addition, component 1 identified as tryptophan (T) clearly segregated sparse MCF10A from the rest of the cells, suggesting that high levels of this metabolite were an idiosyncratic element of the EMT phenotype (Fig. 3b and c) . Taking into account scores on tryptophan and fatty acids (Fig. 3b) , the aggressive metastatic phenotype of MDA-MB-435 cells was strongly associated with an increase in phospholipids with low tryptophan content (Fig. 3b) . On the other hand, MDA-MB-435 cells were split into two clear groups, one with low lipid content and the other with the highest lipid content, according to its heterogeneity [46] . Moreover, in Fig. 3d , it was possible to distinguish the highest fatty acid SP435A cells (with a lipid phenotype) from SP435B cells (with a low lipid concentration and increased levels of component 4), suggesting that this component may act as an alternative fuel source for MDA-MB-435 cells with a lower lipid content [46] . In addition, some bands in component 4 (see Table 1 ) can be assigned to polysaccharides (PS). Therefore, component 4 could be related to glucose metabolism. Furthermore, the cloud of sparse MCF10A cells was displaced with respect to confluent MCF10A cells in Fig. 2d . Sparse MCF10A showed a high LP and low PS content whereas confluent MCF10A have higher PS and lower LP which supports PS as an alternative fuel source for low lipid accumulating cells.
To support MCR results and investigate the biomarker usefulness of RS for diagnostic applications, we performed a PLS-DA model in order to explore the ability of RS to differentiate between sparse and confluent MCF10A and MDA-MB-435 cells. The model (Fig. 4) gave 100% sensitivity and 100% specificity for discrimination of sparse MCF10A, 94% sensitivity and 89% specificity for confluent MCF10A and 80% sensitivity and 100% specificity for MDA-MB-435 using the cross validation method venetian blinds with 7 splits. Overall we presented a clear stratification method to differentiate the characteristic fatty acid accumulation, which enriched by the increased tryptophan concentration in sparse MCF10A cells constituted an initial EMT progression phenotype.
Differential expression of EMT genes supports RS metabolic phenotype
We performed functional enrichment analyses to support the spectral differences between confluent and sparse MCF10A cells according to transcriptomic analysis. We used public transcriptomic data downloaded from Gene Expression Omnibus database GSE8430 [12] to search for functional differences between sparse and confluent cells. This dataset contains a normalized log ratio (z-score) for the differences in expression of 11,500 probe sets representing 9300 genes from the CNIO Homo sapiens Oncochip 2. Genes were ranked by their median z-score and gene set enrichment analysis (GSEA) algorithm [47] was applied to identify specific functions in the list of pre-ranked genes. A total of 71 gene sets including the keywords "fatty acid", "lipid", "glucose", "cholesterol", "EMT" and "tryptophan", and those gene sets described by Charafe et al. [34] , including genes that are differentially expressed in different kinds of breast cancer, were tested ( Table 2) .
Genes that were downregulated in luminal-like breast cancer cell lines in comparison with mesenchymal-like ones [34] were expressed in sparse MCF10A (FDR b 0.000), whereas confluent MCF10A contained genes that were upregulated in luminal-like breast cancer cell lines in comparison with the mesenchymal-like ones (FDR b 0.000). As expected, sparse cells showed a significant enrichment in genes that were upregulated in EMT whereas confluent cells were enriched in EMT downregulated genes, pointing to a mesenchymal phenotype. Surprisingly, both up-and downregulated EMT genes described by Jechlinger et al. [48] were significant gene sets in confluent cells, but downregulated genes were much more statistically significant (FDR = 0.008).
Fatty acid and glucose metabolic functions differentiated confluent and sparse MCF10A cells. The metabolic phenotype of sparse MCF10A cells was characterized by genes involved in glucose deprivation (FDR = 0.0020) and glucose transport (FDR = 0.120), whereas in confluent MCF10A cells the profiling showed an enrichment in genes involved in glucose metabolism (FDR = 0.032). Moreover, differences included increased fatty acid metabolism (FDR = 0.240) and fatty acid oxidation (FDR = 0.150) in confluent MCF10A. Since fatty acid metabolism was increased in these cells their glucose dependence was minimized with regard to sparse cells, suggesting that confluent and sparse MCF10A cells have a different metabolic phenotype in both conditions.
One of the first metabolic alterations observed in cancer cells was the higher dependence upon glucose for their growth, the so-called Warburg effect, indicating that the EMT process in sparse MCF10A cells altered their metabolism, giving them more oncogenic properties [49] . Moreover, tryptophan metabolism and tryptophan catabolism were statistically significant functions (FDR = 0.190 and 0.136 respectively) in confluent cells, which expressed lower levels of tryptophan than sparse cells.
Due to the low number of metabolism-related genes represented in the GEO2603 chip that hybridized with sparse and confluent MCF10A cells (Supplementary Table 1) , an alternative analysis using data from Papageorgis et al. [50] was conducted. To assess differences in gene expression, a t-test between all probe sets from three hybridized MII samples (k-ras transfected MCF10A cells without metastasis ability) and MIII samples (k-ras transfected MCF10A cells with ability to metastasize in vivo) was conducted at the transcriptomic level. The 33,853 genes included in the array (Affymetrix U133 Plus 2.0) were ranked by the t-statistic. In this way, positive values corresponded to a MIII phenotype whereas negative values were characteristic of MII. A GSEA using the same gene sets as those in the GSE8430 study was then run. A total of 33,853 genes were hopefully hybridized on the chip, so more metabolism-related genes were included in the functional enrichment analysis. Significantly enriched functions at FDR 25% were found such as regulation of insulin secretion by free fatty acids (FDR = 0.150) in MIII cells, whereas in MII cells (see Table 3 The model gives 100% sensitivity and 100% specificity for sparse MCF10A discrimination (a), 94% sensitivity and 89% specificity for confluent MCF10A discrimination (b), and 80% sensitivity and 100% specificity for MDA-MB-435 identification (c) using the cross-validation method venetian blinds with 7 splits. Interestingly, upregulated genes from the dataset "Sarrio epithelial mesenchymal transition up" were significantly associated with the MIII phenotype, suggesting a parallel between the MIII vs. MII comparison and the sparse MCF10A vs. confluent MCF10A comparison (FDR = 0.013). Along with this gene set, other sets including genes upregulated in EMT were found to be associated with MIII cells, whereas datasets including downregulated genes in EMT were associated with MII cells. As expected, MIII cells showed a more mesenchymal phenotype, with significant gene sets being those genes described by Charafe et al. [34] as downregulated in basal and luminal breast cancer sub-types.
According to these transcriptomic public data, we inferred that fatty acid and glucose metabolic functions differentiate confluent and sparse MCF10A cells, then supporting the RS profile.
Discussion
To our knowledge this study is the first time MCR has been used to deconvolve and track the molecular content of cancer cells during the EMT process, which involves biochemical changes linked with the early metastatic phenotype of cancer cells. We have demonstrated that the unsupervised computational MCR analysis resolves chemically and physically meaningful component spectra from a set of mixed Raman spectra, allowing the assignment of pure molecular spectra to each component deconvolved and its contribution (concentration). MCR is more powerful than the classical PCA technique, in which the spectral signature in principal components can contain negative regions, impeding the assignment of pure molecular spectra [30] . Therefore, MCR is a good candidate for tracking the biochemical composition of a biomedical sample during a transition involving molecular changes such as in the early diagnosis of breast cancer. These results which are in tune with findings of earlier studies carried out with transcriptomics and molecular biological techniques, using normal and cancer cells, further demonstrate the power of RS approaches in diagnostic applications and in the knowledge of molecular processes of cancer cells.
During the last two decades MCR has been applied to a wide range of chemical data [22] [23] [24] and has been adapted to Raman spectral data from biological tissues for imaging their molecular content [25, 38] . High-contrast images of uterine tissue derived using Raman spectra with an empty modelling approach of Multivariate Curve ResolutionAlternating Least Squares [42] have been obtained. We have shown the ability of MCR to track the biochemical composition of a biological sample during a process involving molecular changes. These molecular changes are sometimes masked by background signals in the Raman spectra of cells. This is because cells need to be grown on a substrate (normally glass) that contains Raman and fluorescence bands, and when acquiring the cellular spectra, the focal point needs to be very close to the window, which in some cases covers part of the confocal volume. The ability of MCR to deconvolve pure component spectra and the flexibility of MCR-ALS algorithm to include specific constrains allow these undesired components to be removed and only the inherent changes occurring in cellular RS to be analysed. Our results demonstrate an improvement in the molecular characterization of cells when using RS coupled with MCR-ALS.
MCR performed on the RS of confluent and sparse MCF10A cells identified the metabolic profile of EMT, which is characterized by a decrease in the cytokeratin content and an increase in the fatty acid and tryptophan content. These results are consistent with the gene profile attributed to altered lipid metabolism functions like fatty acid metabolism and fatty acid oxidation, which increase in malignant cells [51] . Moreover, the PLS-DA analysis of the cellular Raman spectra classified EMT cells in the fingerprint region with 100% sensitivity and 100% specificity (see Fig. 4 ), indicating that Raman spectra provide powerful information allowing stratification of cells by their metastasis initiation process phenotype.
MCF10A cells in confluent conditions had the highest content of cytokeratin according to the composition of their pre-EMT cytoskeleton. In contrast, MCF10A cells that undergo EMT and MDA-MB-435 cells contain abundant vimentin cytoskeleton [15] . Overall, there was a clear difference between confluent and sparse MCF10A cells, reflecting the increased EMT of the latter. These cells can thus be stratified using the lipid-accumulating phenotype profile, which has been found in the most aggressive cancer cells and is related to their increased migration in vitro [52] . Studies comparing the Raman spectrum of human breast cancerous and non-cancerous tissues also showed that fatty acid content and lipid profile were significantly different [53, 54] .
Moreover, the increased tryptophan concentration in sparse MCF10A compared to confluent and MDA-MB-435 cells might be secondary to the catabolic activation of L-tryptophan by indoleamine 2,3-dioxygenase (IDO1). The consumption of this amino acid by cancer cells has been related to immune system evasion [55] . Furthermore, the role of IDO1 in tumour cells has been associated with cell cycle regulatory genes, increased proliferation and inhibition of apoptosis [56] . IDO inhibition with siRNA leads to diminished breast cancer cell proliferation [57] . The activation of genes associated with the tryptophan metabolism has been reported in other types of carcinoma such as the cervical carcinoma, indicating a common metabolic change linked to malignancy [58, 59] . Tryptophan metabolism could exert immunological and non-immunological effects, in turn improving cancer progression. Further studies in breast cancer cells are needed to understand the specific role of this metabolite in the EMT process.
The EMT is one of the main mechanisms involved in breast cancer metastasis and most likely contributes to metastasis in all types of carcinoma [49, 60, 61] . Data obtained by the evaluation of RS using MCR were sensitive enough to detect differences in the breast cancer basal phenotype, since all analysed cells have a basal phenotype and share some similarities. The MDA-MB-435 cell population is basically fed by components 2 (fatty acid) and 4 (polysaccharides). Indeed, MDA-MB-435 cells can be split into two clear groups, one with a low lipid content (fatty acid) and higher levels of polysaccharides and the other with a higher lipid content, indicating the important role of lipids as a fuel source for metastatic cells under nutritional deprivation, which in turn could influence metastasis organ-specificity [46, 62] .
Cancer is a very heterogeneous disease with a large number of genetic alterations. The molecular characterization of cancer cells provides interesting insights into breast cancer taxonomy but its implementation in clinical diagnosis is difficult because it is very expensive [63] . RS together with multivariate analysis has shown a high ability to differentiate cells with different degrees of malignancy according to their biochemical composition. This was validated by gene expression analyses, which confirmed that these differences in cell composition were closely associated with alterations in lipid metabolism that are associated with malignancy. Compared with other decomposition techniques used in RS, such as Principal Component Analysis, MCR analysis gives more chemically and physically understandable results.
There is increasing evidence of the association between phospholipids and cancer. The analysis of MCF10A cells showed initial changes in the lipid content of cells associated with their EMT phenotype. In carcinoma cells EMT is related to higher aggressiveness and invasive and metastatic potential [64] . Activation of lipid metabolism is an early event in carcinogenesis and also a hallmark of many cancers [5] . In our attempt to study the metabolic changes involved in the EMT process we analysed sparse MCF10A cells, which show many features of post-EMT cells in in vitro cell culture, such as increased motility [12] . Our results clearly indicate that an increase in phospholipids is associated with the EMT process in breast cells. Characterization of this initial malignant process, which is closely related to metastasis progression, might be useful for diagnostic purposes. The essential hallmarks of cancer are intertwined with altered cancer cell-intrinsic metabolism, either as a consequence or as a cause [2] . New approaches based on a panel of small molecules derived from the analysis of metabolic profiles of cells are being developed to characterize cancer cell-specific metabolism [65] . Many observations during the early period of cancer biology research identified metabolic alterations such as the Warburg effect [49] . In this scenario RS supported by MCR can provide a useful tool with which to assess the biomolecular composition of tumour cells and metastasis-initiating cells. 
